8-KThe WireRoutine
Bylaw Amendment
Filed Sep 27, 2022 · 3y ago · Accession 0001193125-22-252141
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Atara Biotherapeutics, Inc.
- Ticker
- ATRA
- CIK
- 1604464
- Form type
- 8-K
- Filing date
- Sep 27, 2022
- Report date
- Sep 26, 2022
- Document
- d400712d8k.htm
- Size
- 374 KB